Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVEU LIMITED Capital/Financing Update 2021

Sep 30, 2021

65457_rns_2021-09-30_6ebb5939-7bc2-4970-883c-cb9e6437a290.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [164 x 44] intentionally omitted <==

Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 +61 8 6244 9095 www.nanoveu.com

ASX RELEASE

1 October 2021 ASX: NVU

Results of Pro-Rata Non-Renounceable Rights Issue

Nanoveu Limited (“ Nanoveu ” or the “ Company ”) advises that its pro-rata non-renounceable rights issue of one (1) fully paid ordinary share in the capital of the Company ( Share ) for every four (4) Shares held, at an issue price of $0.045 per Share together with one (1) free attaching option for every two (2) Shares subscribed for and issued ( New Option ), to raise up to $2,152,800 (before costs) ( Entitlement Offer ), closed at 5.00pm on 28 September 2021.

The New Options have an exercise price of $0.058 and a two (2) year term.

The Company received applications to subscribe for 10,516,730 new Shares from eligible shareholders under the Entitlement Offer to raise approximately $473,253. This represents approximately 22% of all Shares offered under the Entitlement Offer.

The Company advises that the results of the Entitlement Offer are as follows:

Shares Attaching
Options
Total number of securities offered under the Entitlement Offer 47,840,129 23,920,065
Total number of securities applied for by eligible shareholders 10,516,730 5,258,365
under the Entitlement Offer
Shortfall 37,323,399 18,661,700

The Company’s recently appointed Non-executive Chairman, Mr Scott Beeton, will participate in $100,000 of the Shortfall, representing 2,222,222, Shares and 1,111,111 New Options, and the Company is in discussions to place the balance of the Shortfall.

- Ends -

This announcement has been authorised for release by Nanoveu’s Managing Director and CEO .

For further information, pleasecontact:Alfred ChongManaging Director and CEOt: +65 6557 0155e: [email protected] For media / investor enquiries,please contact:Jane MorganInvestor Relationst: 0405 555 618e: [email protected]

==> picture [164 x 44] intentionally omitted <==

About Nanoveu Limited

We are technology innovators who specialize in modern, cutting-edge nanotechnology that improve the way we live, from reducing contagious transmissions on high touch points to immersive vision-based entertainment. https://www.nanoveu.com/

Nanoshield - is a film which uses a patented polymer of Cuprous embedded film to self-disinfect surfaces. Nanoshield antiviral protection which is available in a variety of shapes and forms, from mobile screen covers, to mobile phone cases and as a PVC commercial film, capable of being applied to a number of surfaces such as doorhandles and push panels. The perfectly clear plastic film contains a layer of charged copper nanoparticles which have antiviral and antimicrobial properties. This technology is also being applied to fabric applications targeting use in the personal protective equipment sector.

EyeFly3D - is a film applied to digital displays that allowed users to experience 3D without the need for glasses on everyday mobile handheld devices.

Customskins - are vending machines capable of precisely applying screen covers to mobile phones with an alignment accuracy of 150 microns.

EyeFyx - currently in research and development stage, EyeFyx is a vision correction solution using hardware and software to manipulate screen output addressing long-sightedness without the need to wear reading glasses.

2/2